Nifty
Sensex
:
:
20875.55
69399.88
-62.15 (-0.30%)
-253.85 (-0.36%)

Pharmaceuticals & Drugs - Global

Rating :
54/99

BSE: 506197 | NSE: BLISSGVS

133.55
06-Dec-2023
  • Open
  • High
  • Low
  • Previous Close
  •  143.65
  •  144.70
  •  132.00
  •  142.75
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  704404
  •  967.14
  •  149.60
  •  69.20

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,397.38
  • 15.83
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,321.63
  • 0.37%
  • 1.50

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 35.06%
  • 8.61%
  • 29.17%
  • FII
  • DII
  • Others
  • 16.31%
  • 6.61%
  • 4.24%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.11
  • -3.51
  • 9.20

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 5.12
  • -5.74
  • 1.93

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 5.62
  • -10.55
  • 1.14

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 18.54
  • 15.67
  • 16.60

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.27
  • 1.57
  • 1.23

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 8.08
  • 7.63
  • 7.14

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Mar 23
Mar 22
Var%
Dec 22
Dec 21
Var%
Net Sales
211.88
172.43
22.88%
159.52
188.66
-15.45%
184.78
167.06
10.61%
205.72
216.26
-4.87%
Expenses
157.51
147.88
6.51%
135.31
149.81
-9.68%
178.54
146.90
21.54%
158.03
182.09
-13.21%
EBITDA
54.37
24.55
121.47%
24.21
38.85
-37.68%
6.24
20.17
-69.06%
47.69
34.16
39.61%
EBIDTM
25.66%
14.23%
15.18%
20.59%
3.38%
12.07%
23.18%
15.80%
Other Income
12.60
2.15
486.05%
5.11
7.01
-27.10%
2.98
12.19
-75.55%
5.65
6.04
-6.46%
Interest
1.45
1.91
-24.08%
1.49
2.11
-29.38%
5.08
1.63
211.66%
1.26
1.04
21.15%
Depreciation
6.39
4.60
38.91%
6.19
4.55
36.04%
4.88
4.27
14.29%
4.64
4.43
4.74%
PBT
59.13
20.19
192.87%
21.65
39.20
-44.77%
-0.75
26.45
-
47.43
-38.86
-
Tax
16.09
4.19
284.01%
7.27
11.72
-37.97%
-4.22
2.99
-
17.64
9.67
82.42%
PAT
43.04
16.00
169.00%
14.38
27.48
-47.67%
3.47
23.47
-85.22%
29.79
-48.53
-
PATM
20.32%
9.28%
9.01%
14.56%
1.88%
14.05%
14.48%
-22.44%
EPS
4.05
1.33
204.51%
1.41
2.48
-43.15%
0.32
1.89
-83.07%
2.68
-4.83
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Net Sales
761.90
751.59
747.45
577.21
689.31
898.57
814.64
798.44
546.89
407.13
344.64
Net Sales Growth
2.35%
0.55%
29.49%
-16.26%
-23.29%
10.30%
2.03%
46.00%
34.33%
18.13%
 
Cost Of Goods Sold
394.54
401.32
390.98
329.71
439.97
612.26
391.13
358.93
237.18
152.77
132.01
Gross Profit
367.36
350.26
356.47
247.49
249.34
286.31
423.52
439.51
309.72
254.37
212.63
GP Margin
48.22%
46.60%
47.69%
42.88%
36.17%
31.86%
51.99%
55.05%
56.63%
62.48%
61.70%
Total Expenditure
629.39
634.26
629.11
470.56
565.99
740.93
617.50
595.70
391.17
303.70
273.42
Power & Fuel Cost
-
7.13
8.25
8.14
5.88
4.76
5.49
5.58
4.72
4.36
2.93
% Of Sales
-
0.95%
1.10%
1.41%
0.85%
0.53%
0.67%
0.70%
0.86%
1.07%
0.85%
Employee Cost
-
86.17
76.15
68.09
53.69
42.32
69.23
61.35
33.74
29.43
23.46
% Of Sales
-
11.47%
10.19%
11.80%
7.79%
4.71%
8.50%
7.68%
6.17%
7.23%
6.81%
Manufacturing Exp.
-
12.24
12.09
7.83
7.07
4.95
4.88
5.39
25.65
29.98
41.44
% Of Sales
-
1.63%
1.62%
1.36%
1.03%
0.55%
0.60%
0.68%
4.69%
7.36%
12.02%
General & Admin Exp.
-
16.50
15.03
12.03
13.27
17.05
39.48
36.36
24.68
17.07
15.16
% Of Sales
-
2.20%
2.01%
2.08%
1.93%
1.90%
4.85%
4.55%
4.51%
4.19%
4.40%
Selling & Distn. Exp.
-
63.95
67.18
31.35
28.83
34.72
62.09
92.46
42.51
47.05
35.12
% Of Sales
-
8.51%
8.99%
5.43%
4.18%
3.86%
7.62%
11.58%
7.77%
11.56%
10.19%
Miscellaneous Exp.
-
46.96
59.43
13.40
17.28
24.86
45.21
35.63
22.71
23.03
35.12
% Of Sales
-
6.25%
7.95%
2.32%
2.51%
2.77%
5.55%
4.46%
4.15%
5.66%
6.76%
EBITDA
132.51
117.33
118.34
106.65
123.32
157.64
197.14
202.74
155.72
103.43
71.22
EBITDA Margin
17.39%
15.61%
15.83%
18.48%
17.89%
17.54%
24.20%
25.39%
28.47%
25.40%
20.67%
Other Income
26.34
17.79
31.49
21.95
39.19
37.63
26.54
12.51
24.35
20.29
28.00
Interest
9.28
10.36
4.74
7.24
7.57
4.41
22.80
19.69
18.61
16.41
17.98
Depreciation
22.10
18.67
17.33
17.23
12.59
8.94
21.38
20.14
13.26
11.30
10.68
PBT
127.46
106.07
127.76
104.13
142.35
181.92
179.49
175.40
148.19
96.02
70.56
Tax
36.78
29.34
31.04
30.16
33.71
55.25
56.63
62.72
48.05
34.63
29.53
Tax Rate
28.86%
27.66%
57.30%
28.96%
26.14%
30.37%
38.98%
35.76%
32.42%
36.07%
41.85%
PAT
90.68
70.85
15.04
68.49
97.26
123.72
58.78
82.04
82.49
59.91
40.99
PAT before Minority Interest
88.28
76.73
23.13
73.97
95.25
126.66
88.66
112.68
100.15
61.39
41.03
Minority Interest
-2.40
-5.88
-8.09
-5.48
2.01
-2.94
-29.88
-30.64
-17.66
-1.48
-0.04
PAT Margin
11.90%
9.43%
2.01%
11.87%
14.11%
13.77%
7.22%
10.28%
15.08%
14.72%
11.89%
PAT Growth
392.29%
371.08%
-78.04%
-29.58%
-21.39%
110.48%
-28.35%
-0.55%
37.69%
46.16%
 
EPS
8.69
6.79
1.44
6.56
9.32
11.85
5.63
7.86
7.90
5.74
3.93

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Shareholder's Funds
883.90
818.70
808.25
735.61
646.00
536.24
486.62
412.62
337.08
286.88
Share Capital
10.42
10.37
10.31
10.31
10.31
10.31
10.31
10.31
10.31
10.31
Total Reserves
864.59
798.40
788.10
725.30
635.68
525.92
476.31
402.31
326.77
276.57
Non-Current Liabilities
42.84
29.20
45.24
46.32
37.99
12.92
32.81
49.55
67.52
95.65
Secured Loans
40.69
23.22
32.60
37.24
32.54
5.92
25.58
29.62
55.03
78.80
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
8.62
2.23
8.79
Long Term Provisions
2.69
1.07
2.50
2.44
1.75
1.91
2.05
1.81
1.40
1.10
Current Liabilities
193.26
233.09
203.64
230.53
207.03
299.40
437.09
378.97
242.68
307.66
Trade Payables
86.39
92.61
74.22
89.92
78.88
58.43
98.25
108.49
80.33
82.35
Other Current Liabilities
54.86
67.85
53.69
57.21
50.24
124.46
99.93
52.76
70.30
42.12
Short Term Borrowings
46.01
60.70
65.04
66.39
64.30
105.66
187.47
62.12
61.04
57.05
Short Term Provisions
6.00
11.93
10.69
17.01
13.61
10.85
51.45
155.60
31.00
126.14
Total Liabilities
1,153.53
1,108.75
1,076.79
1,027.22
904.88
860.04
1,022.90
874.24
662.17
700.35
Net Block
378.05
280.76
233.72
240.97
144.97
136.48
303.86
225.25
234.38
213.31
Gross Block
458.74
343.41
285.10
276.07
169.89
157.47
326.83
300.74
293.82
262.45
Accumulated Depreciation
80.69
62.65
51.38
35.10
24.92
20.99
22.97
75.48
59.44
49.14
Non Current Assets
456.15
331.89
311.59
257.48
211.39
170.25
456.97
291.23
244.66
229.67
Capital Work in Progress
2.80
22.15
2.39
0.00
46.74
0.47
4.03
9.10
0.00
4.33
Non Current Investment
2.84
2.39
0.70
0.72
0.72
6.30
1.05
0.11
0.01
0.01
Long Term Loans & Adv.
17.62
24.42
12.63
14.56
18.63
26.72
11.45
56.77
10.27
12.02
Other Non Current Assets
54.16
1.47
62.15
1.24
0.33
0.29
136.58
0.00
0.00
0.00
Current Assets
697.37
776.86
765.20
769.74
693.49
689.79
565.93
583.00
417.08
469.26
Current Investments
4.96
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
103.06
123.94
98.93
74.14
77.37
59.03
49.30
38.67
33.70
32.53
Sundry Debtors
385.17
392.75
463.82
547.91
460.73
298.48
254.45
300.93
247.47
215.03
Cash & Bank
102.99
177.53
144.55
103.32
106.63
88.86
150.50
78.18
57.29
80.37
Other Current Assets
101.19
14.12
17.55
16.13
48.76
243.41
111.68
165.22
78.62
141.34
Short Term Loans & Adv.
94.56
68.52
40.35
28.24
22.55
146.30
78.44
149.92
60.69
130.30
Net Current Assets
504.11
543.77
561.56
539.21
486.47
390.39
128.84
204.03
174.40
161.60
Total Assets
1,153.52
1,108.75
1,076.79
1,027.22
904.88
860.04
1,022.90
874.23
662.17
700.35

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Cash From Operating Activity
34.31
135.48
63.97
46.70
39.95
17.64
289.47
112.95
48.94
41.15
PBT
106.07
127.76
104.13
128.97
181.91
179.49
175.40
148.19
96.02
70.56
Adjustment
57.92
-31.71
46.29
26.85
-10.97
17.55
36.24
18.18
22.48
24.11
Changes in Working Capital
-85.12
73.37
-57.89
-70.32
-183.07
-140.80
113.48
-8.33
-60.94
-19.30
Cash after chg. in Working capital
78.87
169.42
92.53
85.49
-12.13
56.24
325.13
158.05
57.56
75.36
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-44.56
-33.94
-28.56
-38.79
52.08
-38.61
-35.66
-45.10
-8.63
-34.21
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-7.75
-92.98
-46.99
-47.89
-73.52
50.24
-231.25
-49.84
-38.98
-10.90
Net Fixed Assets
-96.13
-78.37
-10.99
-65.98
-52.48
-1.04
42.08
-5.32
-28.78
-12.86
Net Investments
0.00
0.73
0.01
0.01
0.16
2.37
-0.95
-1.36
0.00
-0.01
Others
88.38
-15.34
-36.01
18.08
-21.20
48.91
-272.38
-43.16
-10.20
1.97
Cash from Financing Activity
-24.94
-23.73
-20.80
-6.30
16.83
-75.98
-10.13
-40.25
-43.26
-8.47
Net Cash Inflow / Outflow
1.62
18.78
-3.82
-7.50
-16.74
-8.10
48.09
22.85
-33.31
21.77
Opening Cash & Equivalents
21.99
13.13
15.34
15.04
36.95
47.41
0.00
5.09
49.57
27.79
Closing Cash & Equivalent
25.01
21.99
13.13
15.34
15.04
36.95
47.41
27.60
16.26
49.57

Financial Ratios

Consolidated /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Book Value (Rs.)
84.01
78.01
77.41
71.32
62.63
51.99
47.18
40.00
32.64
27.67
ROA
6.78%
2.12%
7.03%
9.86%
14.35%
9.42%
11.88%
13.04%
9.01%
6.46%
ROE
9.11%
2.88%
9.64%
13.79%
21.43%
17.34%
25.06%
26.73%
19.74%
15.17%
ROCE
12.22%
6.37%
12.49%
17.02%
26.58%
24.61%
31.06%
32.07%
23.57%
20.56%
Fixed Asset Turnover
1.87
2.38
2.06
3.09
5.49
3.37
2.56
1.85
1.47
1.48
Receivable days
188.89
209.14
319.89
267.05
154.20
123.80
126.33
182.13
206.07
241.81
Inventory Days
55.12
54.42
54.72
40.11
27.70
24.25
20.01
24.04
29.51
34.22
Payable days
81.40
77.87
90.85
56.62
35.01
51.74
67.63
95.25
108.77
148.76
Cash Conversion Cycle
162.62
185.69
283.75
250.53
146.89
96.31
78.70
110.92
126.81
127.26
Total Debt/Equity
0.11
0.13
0.15
0.16
0.16
0.22
0.46
0.32
0.47
0.60
Interest Cover
11.23
12.42
15.38
18.04
42.21
7.37
9.91
8.96
6.85
4.92

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.